绥美凯的价格

(Also known as: Doptabalamid Tablets) is a drug newly developed by GlaxoSmithKline. It is a drug for human immunodeficiency virus. Human immunodeficiency virus, also known as AIDS (AIDS, Acquired Immunodeficiency Syndrome) virus, is a virus that causes defects in the human immune system.

Suimeikai is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV). According to Medical Companion Travel, Suimeike has been launched in China not long ago. Since Suimeike is an imported original drug in China, it is very expensive and most patients cannot afford it. Therefore, many patients choose Suimeikan (alias: Domitabalamid tablets) launched in India. So what is the price of the Indian version of Suimeike?

The price of the Indian version of Suimeikan: Suimeikan produced by the Indian Emcure company, comes in a box of 30 tablets, priced at about RMB 1,000; the price cannot be determined due to floating exchange rates, please consult Medical Travel for the specific price.

Suimeikai (alias: dolutegravir tablets) is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier, and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.

(Alias: Doptabalamid Tablets) The new drug used to treat AIDS brings new hope to AIDS patients. AIDS is an infectious disease that can be transmitted through sexual contact, blood, and mother-to-child transmission. Currently, there is still a lack of effective drugs to cure HIV infection worldwide. It can only reduce the viral load to the maximum and lasting extent and improve the patient's quality of life.

Recommended related hot articles: /newsDetail/71835.html